By identifying a role for Kcnn3 in regulating excessive drinking and negative affective behaviors in stressed, dependent mice, these preclinical studies demonstrate that KCa2 channels are a potential pharmacogenetic target to treat individuals with AUD and may be particularly effective at treating those with comorbid mood disorders. This evidence concerns the gene KCNN3 and mood disorder.